V. Kameshwara Rao
Birla Institute of Technology and Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by V. Kameshwara Rao.
Bioorganic & Medicinal Chemistry Letters | 2011
V. Kameshwara Rao; Bhupender S. Chhikara; Amir Nasrolahi Shirazi; Rakesh Tiwari; Keykavous Parang; Anil Kumar
An efficient and economical method was developed for the synthesis of 3-substituted indoles by one-pot three-component coupling reaction of a substituted or unsubstituted benzaldehyde, N-methylaniline, and indole or N-methylindole using Yb(OTf)(3)-SiO(2) as a catalyst. All the synthesized compounds were evaluated for inhibition of cell proliferation of human colon carcinoma (HT-29), human ovarian adenocarcinoma (SK-OV-3), and c-Src kinase activity. The 4-methylphenyl (4o and 4p) and 4-methoxyphenyl (4q) indole derivatives inhibited the cell proliferation of SK-OV-3 and HT-29 cells by 70-77% at a concentration of 50 μM. The unsubstituted phenyl (4d) and 3-nitrophenyl (4l) derivatives showed the inhibition of c-Src kinase with IC(50) values of 50.6 and 58.3 μM, respectively.
Organic Letters | 2013
V. Kameshwara Rao; Ganesh M. Shelke; Rakesh Tiwari; Keykavous Parang; Anil Kumar
An efficient and simple strategy has been developed for the synthesis of 2,3-diarylnaphthofurans using sequential hydroarylation of naphthols and alkynes in the presence of In(OTf)3 under microwave irradiation followed by one-pot Heck-oxyarylation of generated 1-substituted-α-hydroxy styrenes.
Australian Journal of Chemistry | 2010
Anil Kumar; B M. Sudershan Rao; V. Kameshwara Rao
A simple and efficient chemoselective thioacetalization of carbonyl compounds has been achieved using Ce(OTf)3 (10 mol-%) as a catalyst under solvent-free conditions. Advantages of the methodology include very short reaction times, excellent yields, the catalytic use of a water tolerant Lewis acid, and simple recovery and reuse of the catalyst.
RSC Advances | 2013
V. Kameshwara Rao; Rakesh Tiwari; Bhupender S. Chhikara; Amir Nasrolahi Shirazi; Keykavous Parang; Anil Kumar
A simple, efficient, and environment friendly protocol for the synthesis of 1,3,5-triarylpyrazole and 1,3,5-triarylpyrazolines in [bimm][PF6] ionic liquid mediated by Cu(OTf)2 is described. The reaction protocol gave 1,3,5-triarylpyrazoles in good to high yields (71-84%) via a one-pot addition-cyclocondensation between chalcones and arylhydrazines, and oxidative aromatization without requirement for an additional oxidizing reagent. The catalyst can be reused up to four cycles without much loss in the catalytic activity. The pyrazoles (4a-o) and pyrazolines (3a-n) were evaluated for antiproliferative activity in SK-OV-3, HT-29, and HeLa human cancer cells lines. Among all compounds, 3b inhibited cell proliferation of HeLa cells by 80% at a concentration of 50 μM.
Bioorganic & Medicinal Chemistry Letters | 2012
V. Kameshwara Rao; Bhupender S. Chhikara; Rakesh Tiwari; Amir Nasrolahi Shirazi; Keykavous Parang; Anil Kumar
A number of 2-substituted tetrahydroindazolones were synthesized by three-component condensation reaction of 1,3-diketones, substituted hydrazines, benzaldehydes, and Yb(OTf)(3) as a catalyst in [bmim][BF(4)] ionic liquid using a simple, efficient, and economical one-pot method. The synthesized tetrahydroindazolones were evaluated for inhibition of cell proliferation of human colon carcinoma (HT-29), human ovarian adenocarcinoma (SK-OV-3), and c-Src kinase activity. 3,4-Dichlorophenyl tetrahydroindazolone derivative (15) inhibited the cell proliferation of HT-29 and SK-OV-3 cells by 62% and 58%, respectively. 2,3-Diphenylsubstituted tetrahydroindazolone derivatives, inhibited the cell proliferation of HT-29 cells by 65-72% at a concentration of 50 μM. In general, the tetrahydroindazolones showed modest inhibition of c-Src kinase where 4-tertbutylphenyl- and 3,4-dichlorophenyl- derivatives showed the inhibition of c-Src kinase with IC(50) values of 35.1 and 50.7 μM, respectively.
Bioorganic & Medicinal Chemistry Letters | 2013
Kasiviswanadharaju Pericherla; Amir Nasrolahi Shirazi; V. Kameshwara Rao; Rakesh Tiwari; Nicholas A. DaSilva; Kellen McCaffrey; Yousef A. Beni; Antonio González-Sarrías; Navindra P. Seeram; Keykavous Parang; Anil Kumar
Simple and efficient synthesis of quebecol and a number of its analogs was accomplished in five steps. The synthesized compounds were evaluated for antiproliferative activities against human cervix adenocarcinoma (HeLa), human ovarian carcinoma (SK-OV-3), human colon carcinoma (HT-29), and human breast adenocarcinoma (MCF-7) cancer cell lines. Among all the compounds, 7c, 7d, 7f, and 8f exhibited antiproliferative activities against four tested cell lines with inhibition over 80% at 75 μM after 72 h, whereas, compound 7b and 7g were more selective towards MCF-7 cell line. The IC50 values for compounds 7c, 7d, and 7f were 85.1 μM, 78.7 μM, and 80.6 μM against MCF-7 cell line, respectively, showing slightly higher antiproliferative activtiy than the synthesized and isolated quebecol with an IC50 value of 104.2 μM against MCF-7.
Synlett | 2011
Anil Kumar; V. Kameshwara Rao
RSC Advances | 2013
Ganesh M. Shelke; V. Kameshwara Rao; Rakesh Tiwari; Bhupender S. Chhikara; Keykavous Parang; Anil Kumar
Synthesis | 2015
V. Kameshwara Rao; Pinku Kaswan; Ganesh M. Shelke; Ashley Ryan; Mukund Jha; Anil Kumar
Archive | 2015
G. Jaya Krishna; V. Kameshwara Rao; M. Prabhudeva; A. Ravi Kumar; A. Jaya; Rami Reddy; V. Vallabh